scholarly journals XBP1 links the 12-hour clock to NAFLD and regulation of membrane fluidity and lipid homeostasis

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Huan Meng ◽  
Naomi M. Gonzales ◽  
David M. Lonard ◽  
Nagireddy Putluri ◽  
Bokai Zhu ◽  
...  

AbstractA distinct 12-hour clock exists in addition to the 24-hour circadian clock to coordinate metabolic and stress rhythms. Here, we show that liver-specific ablation of X-box binding protein 1 (XBP1) disrupts the hepatic 12-hour clock and promotes spontaneous non-alcoholic fatty liver disease (NAFLD). We show that hepatic XBP1 predominantly regulates the 12-hour rhythmicity of gene transcription in the mouse liver and demonstrate that perturbation of the 12-hour clock, but not the core circadian clock, is associated with the onset and progression of this NAFLD phenotype. Mechanistically, we provide evidence that the spliced form of XBP1 (XBP1s) binds to the hepatic 12-hour cistrome to directly regulate the 12-hour clock, with a periodicity paralleling the harmonic activation of the 12-hour oscillatory transcription of many rate-limiting metabolic genes known to have perturbations in human metabolic disease. Functionally, we show that Xbp1 ablation significantly reduces cellular membrane fluidity and impairs lipid homeostasis via rate-limiting metabolic processes in fatty acid monounsaturated and phospholipid remodeling pathways. These findings reveal that genetic disruption of the hepatic 12-hour clock links to the onset and progression of NAFLD development via transcriptional regulator XBP1, and demonstrate a role for XBP1 and the 12-hour clock in the modulation of phospholipid composition and the maintenance of lipid homeostasis.

2020 ◽  
Vol 11 ◽  
Author(s):  
Youli Yao ◽  
Along Zuo ◽  
Qiyu Deng ◽  
Shikang Liu ◽  
Tianying Zhan ◽  
...  

The circadian clock plays a key role in our daily physiology and metabolism. Alcohol consumption disrupts the circadian rhythm of metabolic genes in the liver; however, the potential contribution of circadian clock modulation to alcoholic liver disease (ALD) is unknown. We identified a novel liver protective agent, physcion, which can alleviate fat accumulation and inflammation in ALD mice via reprogramming the hepatic circadian clock. The model of alcoholic hepatitis was established by intragastrically administering ethanol. In vitro, physcion was investigated by treating HepG2 cells with ethanol. The role of circadian clock in Physcion caused liver protection was tested by knocking down the core circadian gene Bmal1. Physcion application caused reduced lipogenesis and alleviated inflammation in alcohol-induced mice. In alcoholic hepatosteatosis models, physcion upregulated the core circadian genes. And the circadian misalignment triggered by ethanol was efficiently reversed by physcion. Physcion attenuated lipogenesis via reprogramming the circadian clock in HepG2 cells. Suppression of Bmal1 by RNA interference abolished the protective of physcion. In addition, Physcion binds to the active pocket of BMAL1 and promotes its expression. The study identified the novel liver protective effects of physcion on alcohol-induced liver injury, and modulation of the core circadian clock regulators contributes to ALD alleviation. More importantly, strategies targeting the circadian machinery, for example, Bmal1, may prove to be beneficial treatment options for this condition.


2018 ◽  
Vol 1 (1) ◽  
pp. 42-49
Author(s):  
Panida Thong-u-thaisri

Non-alcoholic fatty liver disease (NAFLD) เป็นสาเหตุของโรคตับเรื้อรังที่สำคัญ ผู้ป่วย steatosis ส่วนหนึ่งจะดำเนินโรคเป็น nonalcoholic steatohepatitis (NASH) สร้าง fibrosis เป็นโรคตับแข็งและมะเร็งตับ ภาวะดื้ออินซูลินเป็นสาเหตุสำคัญของการเกิด NAFLD นำไปสู่ภาวะ adipose tissue dysfunction เสียสมดุลในการหลั่ง adipocytokine ร่วมกับมี mitochondrial dysfunction และการเปลี่ยนแปลงที่ endoplasmic reticulum ส่งผลต่อ lipid homeostasis การอักเสบและ apoptosis และ hepatic stellate cells เปลี่ยนแปลงเป็น myofibroblasts สร้าง fibrosis  การทำ liver biopsy ถือว่าเป็น gold standard ในการวินิจฉัย NASH และ fibrosis พิจารณาในรายที่มี metabolic syndrome หรือมี significant fibrosis จากตรวจ noninvasive tests  การรักษา NAFLD แนะนำ lifestyle modification คุมอาหาร ลดน้ำหนัก ออกกำลังกายและรักษา metabolic risk factors เช่น อ้วน เบาหวาน ความดันโลหิตสูง ไขมันในเลือดสูงและ obstructive sleep apnea  ยาที่ใช้ในการรักษา biopsy-proven NASH ได้แก่ pioglitazone และ vitamin E และ promising drug ในการรักษา NASH ได้แก่ GLP-1 agonist และ SGLT2 inhibitor ในอนาคตยาที่รักษา NAFLD ออกฤทธิ์ตาม pathogenesis เช่น ลดไขมันสะสมตับ  ลดการอักเสบ antioxidants  ยับยั้ง apoptosis ปรับเปลี่ยน intestinal microbiomes และยับยั้งการเกิด fibrosis


Cells ◽  
2018 ◽  
Vol 7 (12) ◽  
pp. 230 ◽  
Author(s):  
Laura Listenberger ◽  
Elizabeth Townsend ◽  
Cassandra Rickertsen ◽  
Anastasia Hains ◽  
Elizabeth Brown ◽  
...  

Alcoholic fatty liver disease (AFLD) is characterized by an abnormal accumulation of lipid droplets (LDs) in the liver. Here, we explore the composition of hepatic LDs in a rat model of AFLD. Five to seven weeks of alcohol consumption led to significant increases in hepatic triglyceride mass, along with increases in LD number and size. Additionally, hepatic LDs from rats with early alcoholic liver injury show a decreased ratio of surface phosphatidylcholine (PC) to phosphatidylethanolamine (PE). This occurred in parallel with an increase in the LD association of perilipin 2, a prominent LD protein. To determine if changes to the LD phospholipid composition contributed to differences in protein association with LDs, we constructed liposomes that modeled the LD PC:PE ratios in AFLD and control rats. Reducing the ratio of PC to PE increased the binding of perilipin 2 to liposomes in an in vitro experiment. Moreover, we decreased the ratio of LD PC:PE in NIH 3T3 and AML12 cells by culturing these cells in choline-deficient media. We again detected increased association of specific LD proteins, including perilipin 2. Taken together, our experiments suggest an important link between LD phospholipids, protein composition, and lipid accumulation.


2020 ◽  
Vol 11 (8) ◽  
pp. 7183-7196 ◽  
Author(s):  
Chuang Guo ◽  
Han Xue ◽  
Tian Guo ◽  
Wei Zhang ◽  
Wen-Qiang Xuan ◽  
...  

Lactoferrin was shown to possess antioxidant and anti-inflammatory properties and exert modulatory effects on lipid homeostasis and non-alcoholic fatty liver disease, but our understanding of its regulatory mechanisms is limited and inconsistent.


2019 ◽  
Vol 10 ◽  
Author(s):  
Dongmei Shi ◽  
Jie Chen ◽  
Jiaofeng Wang ◽  
Jianfeng Yao ◽  
Yiqin Huang ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (11) ◽  
pp. 1778 ◽  
Author(s):  
Mazzoccoli ◽  
Miele ◽  
Marrone ◽  
Mazza ◽  
Vinciguerra ◽  
...  

The biological clock controls at the molecular level several aspects of mammalian physiology, by regulating daily oscillations of crucial biological processes such as nutrient metabolism in the liver. Disruption of the circadian clock circuitry has recently been identified as an independent risk factor for cancer and classified as a potential group 2A carcinogen to humans. Hepatocellular carcinoma (HCC) is the prevailing histological type of primary liver cancer, one of the most important causes of cancer-related death worldwide. HCC onset and progression is related to B and C viral hepatitis, alcoholic and especially non-alcoholic fatty liver disease (NAFLD)-related milieu of fibrosis, cirrhosis, and chronic inflammation. In this review, we recapitulate the state-of-the-art knowledge on the interplay between the biological clock and the oncogenic pathways and mechanisms involved in hepatocarcinogenesis. Finally, we propose how a deeper understanding of circadian clock circuitry–cancer pathways’ crosstalk is promising for developing new strategies for HCC prevention and management.


2021 ◽  
Vol 11 ◽  
Author(s):  
Aldo Grefhorst ◽  
Ivo P. van de Peppel ◽  
Lars E. Larsen ◽  
Johan W. Jonker ◽  
Adriaan G. Holleboom

Non-alcoholic fatty liver disease (NAFLD) or metabolic (dysfunction) associated liver disease (MAFLD), is, with a global prevalence of 25%, the most common liver disorder worldwide. NAFLD comprises a spectrum of liver disorders ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis and eventually end-stage liver disease. The cause of NAFLD is multifactorial with genetic susceptibility and an unhealthy lifestyle playing a crucial role in its development. Disrupted hepatic lipid homeostasis resulting in hepatic triglyceride accumulation is an hallmark of NAFLD. This disruption is commonly described based on four pathways concerning 1) increased fatty acid influx, 2) increased de novo lipogenesis, 3) reduced triglyceride secretion, and 4) reduced fatty acid oxidation. More recently, lipophagy has also emerged as pathway affecting NAFLD development and progression. Lipophagy is a form of autophagy (i.e. controlled autolysosomal degradation and recycling of cellular components), that controls the breakdown of lipid droplets in the liver. Here we address the role of hepatic lipid homeostasis in NAFLD and specifically review the current literature on lipophagy, describing its underlying mechanism, its role in pathophysiology and its potential as a therapeutic target.


Sign in / Sign up

Export Citation Format

Share Document